- Home
- MRVI vs JRS Comparison
MRVI vs JRS Comparison
Compare MRVI & JRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRVI
- JRS
- Stock Information
- Founded
- MRVI 2014
- JRS 2001
- Country
- MRVI United States
- JRS United States
- Employees
- MRVI N/A
- JRS N/A
- Industry
- MRVI Biotechnology: Pharmaceutical Preparations
- JRS Finance/Investors Services
- Sector
- MRVI Health Care
- JRS Finance
- Exchange
- MRVI Nasdaq
- JRS Nasdaq
- Market Cap
- MRVI 262.9M
- JRS 216.7M
- IPO Year
- MRVI 2020
- JRS N/A
- Fundamental
- Price
- MRVI $1.98
- JRS $7.94
- Analyst Decision
- MRVI Hold
- JRS
- Analyst Count
- MRVI 9
- JRS 0
- Target Price
- MRVI $6.54
- JRS N/A
- AVG Volume (30 Days)
- MRVI 1.6M
- JRS 86.6K
- Earning Date
- MRVI 05-12-2025
- JRS 01-01-0001
- Dividend Yield
- MRVI N/A
- JRS 8.87%
- EPS Growth
- MRVI N/A
- JRS N/A
- EPS
- MRVI N/A
- JRS N/A
- Revenue
- MRVI $259,185,000.00
- JRS N/A
- Revenue This Year
- MRVI N/A
- JRS N/A
- Revenue Next Year
- MRVI $14.23
- JRS N/A
- P/E Ratio
- MRVI N/A
- JRS N/A
- Revenue Growth
- MRVI N/A
- JRS N/A
- 52 Week Low
- MRVI $1.67
- JRS $5.95
- 52 Week High
- MRVI $11.56
- JRS $8.00
- Technical
- Relative Strength Index (RSI)
- MRVI 43.17
- JRS 54.44
- Support Level
- MRVI $1.96
- JRS $7.81
- Resistance Level
- MRVI $2.16
- JRS $8.09
- Average True Range (ATR)
- MRVI 0.13
- JRS 0.14
- MACD
- MRVI 0.04
- JRS 0.05
- Stochastic Oscillator
- MRVI 47.67
- JRS 75.00
About MRVI Maravai LifeSciences Holdings Inc.
Maravai LifeSciences Holdings Inc is a life sciences company that provides critical products that drive the development of groundbreaking vaccines, drug therapies, cell and gene therapies, and diagnostics. The group's solutions empower research into human diseases and support the entire biopharmaceutical development process from early discovery to commercialization. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.
About JRS Nuveen Real Estate Income Fund of Beneficial Interest
Nuveen Real Estate Income Fund is a diversified closed-end investment company. The Fund invests primarily in income-producing common stocks, preferred stocks, convertible preferred stocks, and debt securities issued by real estate companies.